1. Home
  2. TECX vs EVC Comparison

TECX vs EVC Comparison

Compare TECX & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$23.33

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

N/A

Current Price

$6.74

Market Cap

683.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
EVC
Founded
2019
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
683.9M
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
TECX
EVC
Price
$23.33
$6.74
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $76.63
N/A
AVG Volume (30 Days)
233.3K
★ 1.2M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
★ 2.95%
EPS Growth
40.70
★ 47.59
EPS
N/A
★ 0.32
Revenue
N/A
★ $536,034,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$21.19
Revenue Growth
N/A
N/A
52 Week Low
$15.45
$1.95
52 Week High
$39.53
$13.74

Technical Indicators

Market Signals
Indicator
TECX
EVC
Relative Strength Index (RSI) 33.51 25.76
Support Level $20.52 $2.89
Resistance Level $30.80 $10.09
Average True Range (ATR) 1.39 0.30
MACD 0.11 -0.03
Stochastic Oscillator 27.11 18.33

Price Performance

Historical Comparison
TECX
EVC

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: